1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
4.1. Product Pipeline
5. UNITED STATES RUO IMMUNOASSAY MARKET BY PRODUCT TYPE
5.1. Introduction
5.2. Immunoassay Kits
5.2.1. Enzyme-Linked Immunosorbent Assay (ELISA) Kits
5.2.1.1. Conventional
5.2.1.2. Manual
5.2.2. Radioimmunoassay (RIA Kits)
5.2.2.1. Conventional
5.2.2.2. Manual
5.2.3. Chemiluminescent Immunoassay (CLIA) Kits
5.3. Immunoassay Reagents
5.4. Microplate Reader
5.5. Microplates
5.6. Analyzers
5.6.1. Automated Analyzers
5.6.2. Non-Automated Analyzers
5.7. Microplate Washers
5.8. Others
6. UNITED STATES RUO IMMUNOASSAY MARKET BY SAMPLE TYPE
6.1. Introduction
6.2. Plasma
6.3. Blood Serum
6.4. Urine
6.5. Saliva
6.6. Cell or Tissue Culture Medium
6.7. Others
7. UNITED STATES RUO IMMUNOASSAY MARKET BY APPLICATION
7.1. Introduction
7.2. Oncology
7.3. Blood Screening and Toxicology
7.4. Infectious Disease
7.5. Cardiology
7.6. Allergy Diagnostic
7.7. Rare and Emerging Condition Diagnostic
7.8. Others
8. UNITED STATES RUO IMMUNOASSAY MARKET BY END-USER
8.1. Introduction
8.2. Research and Academic Laboratories
8.3. Pharmaceutical and Biotechnology Companies
9. UNITED STATES RUO IMMUNOASSAY MARKET BY STATE
9.1. Introduction
9.2. California
9.2.1. By Product Type
9.2.2. By Sample Type
9.2.3. By Application
9.2.4. By End-User
9.3. Texas
9.3.1. By Product Type
9.3.2. By Sample Type
9.3.3. By Application
9.3.4. By End-User
9.4. Florida
9.4.1. By Product Type
9.4.2. By Sample Type
9.4.3. By Application
9.4.4. By End-User
9.5. New York
9.5.1. By Product Type
9.5.2. By Sample Type
9.5.3. By Application
9.5.4. By End-User
9.6. Pennsylvania
9.6.1. By Product Type
9.6.2. By Sample Type
9.6.3. By Application
9.6.4. By End-User
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. F-Hoffmann-La Roche AG
11.2. Abbott Laboratories
11.3. Siemens Healthineers
11.4. Danaher Corporation (Beckman Coulter, Inc.)
11.5. Thermo Fisher Scientific
11.6. DIAsource
11.7. BioCheck, Inc
11.8. Berthhold Technologies GmbH & Co.
11.9. IBL International
11.10. bioMérieux SA
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES